JPMorgan Chase & Co’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-13,287
| Closed | -$68K | – | 5053 |
|
|
2019
Q2 | $68K | Buy |
13,287
+1,978
| +17% | +$10.1K | ﹤0.01% | 4146 |
|
|
2019
Q1 | $41K | Sell |
11,309
-39,116
| -78% | -$142K | ﹤0.01% | 4307 |
|
|
2018
Q4 | $310K | Buy |
50,425
+39,899
| +379% | +$245K | ﹤0.01% | 3602 |
|
|
2018
Q3 | $61K | Sell |
10,526
-50,955
| -83% | -$295K | ﹤0.01% | 4290 |
|
|
2018
Q2 | $262K | Buy |
61,481
+53,147
| +638% | +$226K | ﹤0.01% | 3721 |
|
|
2018
Q1 | $37K | Sell |
8,334
-1,242
| -13% | -$5.51K | ﹤0.01% | 4247 |
|
|
2017
Q4 | $50K | Buy |
9,576
+9,448
| +7,381% | +$49.3K | ﹤0.01% | 4138 |
|
|
2017
Q3 | $1K | Buy |
+128
| New | +$1K | ﹤0.01% | 4263 |
|
|
2017
Q1 | – | Sell |
-19,958
| Closed | -$143K | – | 4615 |
|
|
2016
Q4 | $143K | Buy |
+19,958
| New | +$143K | ﹤0.01% | 3770 |
|
|
2016
Q3 | – | Sell |
-3,663
| Closed | -$23K | – | 4377 |
|
|
2016
Q2 | $23K | Sell |
3,663
-104
| -3% | -$653 | ﹤0.01% | 3692 |
|
|
2016
Q1 | $21K | Buy |
+3,767
| New | +$21K | ﹤0.01% | 3587 |
|
|
2015
Q1 | – | Sell |
-333,616
| Closed | -$5.95M | – | 3573 |
|
|
2014
Q4 | $5.95M | Sell |
333,616
-252,927
| -43% | -$4.51M | ﹤0.01% | 1971 |
|
|
2014
Q3 | $5.89M | Sell |
586,543
-47,128
| -7% | -$473K | ﹤0.01% | 1931 |
|
|
2014
Q2 | $9.89M | Sell |
633,671
-110,979
| -15% | -$1.73M | ﹤0.01% | 1713 |
|
|
2014
Q1 | $13.8M | Sell |
744,650
-12,187
| -2% | -$226K | ﹤0.01% | 1516 |
|
|
2013
Q4 | $14.5M | Buy |
756,837
+304,144
| +67% | +$5.81M | ﹤0.01% | 1449 |
|
|
2013
Q3 | $7.4M | Sell |
452,693
-273,507
| -38% | -$4.47M | ﹤0.01% | 1816 |
|
|
2013
Q2 | $5.49M | Buy |
+726,200
| New | +$5.49M | ﹤0.01% | 1904 |
|